SCHEMBL6786495

SCHEMBL6786495

COc1cc2[nH]cc(Br)c(=O)c2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ POLB P06746 1/20 0.46
▸ GRIN2D O15399 2/20 0.46
▸ GRIN3B O60391 2/20 0.46
▸ GRIN1 Q05586 2/20 0.46
▸ GRIN2A Q12879 2/20 0.46
▸ GRIN2B Q13224 2/20 0.46
▸ GRIN2C Q14957 2/20 0.46
▸ GRIN3A Q8TCU5 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ LMNA P02545 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MTNR1A P48039 2/20 0.43
▸ MTNR1B P49286 2/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ PDE3B Q13370 3/20 0.42
▸ PDE3A Q14432 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27509094 0.85 MTNR1A (0.44) KDM4EMAPK1POLBGRIN2DGRIN3B
SCHEMBL2063876 0.83 CTSV (0.64) POLBALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL19147143 0.81 KDM4E (0.51) KDM4EMAPK1POLBGRIN2DGRIN3B
SCHEMBL2749368 0.79 KDM4E (0.50) KDM4EMAPK1POLBGRIN2DGRIN3B
SCHEMBL6783400 0.79 KDM4E (0.50) KDM4EMAPK1POLBGRIN2DGRIN3B
SCHEMBL256579 0.79 KDM4E (0.50) KDM4EMAPK1POLBGRIN2DGRIN3B
SCHEMBL8029115 0.77 ALDH1A1 (0.56) KDM4EALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL7282665 0.76 MTNR1A (0.53) KDM4EMAPK1POLBGRIN2DGRIN3B
SCHEMBL4765036 0.76 KDM4E (0.47) KDM4EMAPK1POLBGRIN2DGRIN3B
SCHEMBL9424983 0.76 KDM4E (0.64) KDM4EMAPK1POLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6809106-B1 ANTIPROLIFERATION AGENTS; SUCH AS 4-(2-METHOXYPHENOXY)-ANILINO-3-CHLORO-6,7-DIMETHOXYQUINOLINE ASTRAZENECA AB (SE) 2004-10-26 — — US disclosed
EP-1178966-B1 QUINOLINE DERIVATIVES AS INHIBITORS OF MEK ENZYMES ASTRAZENECA AB (SE) 2003-10-22 — — EP disclosed
EP-1178966-A1 QUINOLINE DERIVATIVES AS INHIBITORS OF MEK ENZYMES AstraZeneca AB (SE) 2002-02-13 — — EP disclosed
WO-2000068200-A1 QUINOLINE DERIVATIVES AS INHIBITORS OF MEK ENZYMES ASTRAZENECA AB (SE) 2000-11-16 — — WO disclosed
Send feedback